| Name | Title | Contact Details |
|---|
Sente, Inc., a privately held specialty aesthetics company, is a recognized leader in the development of innovative and targeted medical grade skincare products utilizing HSA technology, a low molecular weight formulation of heparan sulfate. HSA plays a key role in the development of new collagen and the promotion of skin renewal to fight the signs of aging. Sente was founded in 2007 and is based in San Diego, California.
Boundless is a new technology company providing immigrants with the tools, information, and personalized support to navigate their immigration journey with confidence.
PLUS is a California-based cannabis company that`s all about addition and stepping up our game. PLUS isn`t just a name, it`s what we do. We believe that what we`re adding to the edibles category — consistency, safety, flavor, taste, innovation — expands the accessibility of cannabis, enriches the experience and elevates the industry. We hold ourselves to a higher standard than what is required. You could say we go above & beyond for our customers, ensuring they have an extraordinary experience each and every time they pop a PLUS product. PLUS was one of the first and few edible brands to bring testing in house, testing over 8x per batch, to ensure consistency for the consumer. PLUS is all about empowering customers to enhance life`s everyday moments through a personalized approach to cannabis. Our tagline is “Find Your Just Right” because we believe there`s something for everyone in our portfolio. We constantly renovate and innovate to ensure we are creating a tailored experience for a wide range of cannabis consumers.
This technology was created for something much bigger than beauty, so we wanted to make sure we got it right. After six years of continued testing, multiple patents, and many, many sleepless nights, we`re finally ready to share our product with the world. By balancing science with beauty, we’re able to put a little good back into the hands of everyone.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.